Access Proof of Concept

Through a 10,000-square-foot AAALAC-accredited vivarium that is staffed with experts in preclinical oncology research, our clients have access to more than 300 human tumor and murine tumor models that represent all of the major histologies, as well as rare disease. As part of that collection, you can:

  • Make Selection Easier: Many lines have been characterized using gene expression profiling data that can guide cell line model selection.
  • Diversify Model Sampling: In addition to traditional subcutaneous xenograft models, TD2 also offers tumor cell lines as orthotopic and metastatic models, and can incorporate imaging into these studies with available light-emitting cell lines. 
  • Get Clear Results: In vivo efficacy studies are designed to identify optimal and streamlined development strategies for your experimental agent—with endpoints of tumor growth inhibition (TGI), tumor growth delay (TGD/survival), imaging endpoints and biomarker analysis.

Get High-Tech Optimal Imaging Resources

Facilitate preclinical optical imaging with a multi-modal AMI 1000 designed for powerful bioluminescence, fluorescence and X-ray.

Glean Early Insights About Toxicity

Through non-GLP toxicology assessments—including dose range finding, pharmacokinetic analysis, CBC and blood chemistries, and highly sophisticated histopathology services—you can glean early insights into a drug's activity and toxicity, which can be added to any in vivo study as secondary endpoints.

Store and Access Data, Securely

Get accurate data collection and reporting through StudyLog®, our electronic data collection software—which also enables more reliable data collection and faster analysis. Access your data (individual/group mean tumor volumes, body weights, graphs, and observations) through our secure data room at any point through the study.

Ask us how you can get your preclinical plan started today.